As part of the Salvatierra Lecture Series, Timothy Pruett, MD, will present “The Canary in the Coal Mine: Transplantation in the Era of Transparency.” About Dr. Pruett:
- Professor of Surgery and Internal Medicine, Chief of Transplantation and the John S. Najarian Surgical Chair in Clinical Transplantation at University of Minnesota
- Chair of the ASTS/AST joint committee for Biovigilance
- Medical degree from the Baylor College of Medicine
- General Surgery and Transplantation training at the University of Minnesota
- Internal Medicine residency at the University of Michigan
As part of the Chandler Lecture Series, Steven Rothenberg, MD, will present “A quarter century of developing thoracoscopic surgery in infants and children.”
About Dr. Rothenberg:
- Chief of Pediatric Surgery at Rocky Mountain Hospital for Children at Presbyterian/St. Luke’s in Denver, Colorado
- Professor of Surgery at Columbia University in New York City
- “SAGES Pioneer in Surgical Endoscopy” for 2015
Dr. Megan Sykes of CUMC will present.
Marc Levitt, Md of Nationwide Children’s Hospital will present.
The 22nd Annual Thomas J. Fogarty, MD Lecture: Focus on Innovation
Friday, October 30, 2020 | 4pm
LKSC – Berg Hall | Stanford University
Featuring Julio C. Palmaz, MD, radiologist, honorary Ashbel Smith Professor at the University of Texas Health Science Center, inventor, entrepreneur, and vintner.
The Fogarty lectureship was established to bring together a diverse community in Silicon Valley focusing on leaders in discovery, invention, innovation, and entrepreneurship. This event is sponsored by Stanford Byers Center for Biodesign, Fogarty Institute for Innovation and Stanford Department of Surgery. Watch this space for more information.
Mir Imran has accepted the invitation to be the 24th annual Fogarty guest lecturer. The date of the event is Friday September 30, 2022 at 4pm. It will be a hybrid event.
Mir Imran, Chairman & CEO of InCube Labs, is a prolific healthcare innovator and entrepreneur, who has been developing and commercializing breakthrough medical innovations for over 40 years.
Mir began his career as a healthcare entrepreneur in the late 1970’s with his pioneering contributions to the first FDA-approved Implantable Defibrillator (ICD). Since then, Mir has founded more than 20 life sciences companies and two tech companies, 15 of which have seen liquidity events (IPO/Acquisition). His most recent exit, Rani Therapeutics Holdings Inc., went public on Nasdaq in July 2021.
Mir’s inventions have saved the lives of millions of patients, and many have become the standards of care. He has developed innovative therapies for a number of chronic diseases, including, anemia, chronic pain, stroke, diabetes, and several cardiovascular conditions. His recent company, Rani Therapeutics, is revolutionizing the management of chronic diseases, by replacing painful injectable therapies with oral biologics.
Mir holds more than 800 issued & pending US patents. In 2016, QMed named Mir as one of the “Top 50 Medical Inventors of All Time”. Mir is a fellow of the National Academy of Engineering, the National Academy of Inventors and the American Institute of Medical & Biological Engineers. In 2009, Mir was inducted into the Rutgers University Hall of Distinguished Alumni.
Mir is also the co-founder & managing director of InCube Ventures, LP, a medtech/biotech venture capital fund. In addition, Mir serves on the boards of several life science companies, on the advisory board of the Lemelson Foundation, and is a trustee of the UCSC Foundation. He is also an Adjunct Professor of Bioengineering at the University of Pittsburgh and actively supports the promotion and teaching of innovation and entrepreneurship at colleges and universities. As a philanthropist, Mir is passionately supporting education in India and US, especially for underprivileged students.